NCAM1 and myelodysplastic syndrome: Increased percentages of CD14+CD56+ monocytes (> 18%) were found in 6 (43%) MDS patients but in none of the healthy individuals, and in most of the patients (4, 29%), CD14+CD56+ monocytes were markedly increased (> 28%).